
| Serial Number | 99748811 |
| Word Mark | CODABLE |
| Filing Date | Tuesday, April 7, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, April 7, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Machine learning software; machine learning software for analysis; software for predicting protein expression; computer software platforms; software relating to medical research; algorithms, being computer software; downloadable computer software programs; computer applications in the fields of recombinant protein production, genetic engineering, immunology, cell engineering, biopharmaceuticals, biotechnology, molecular biology, modulating therapeutics, assay systems and antigens; software in the field of culture methods for microbes, bacteria, yeast, fungi and mammalian cells; software in the fields of genomes, genetic mapping, molecular genetics, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assays; downloadable software, namely, lab information management systems; downloadable software for remote diagnostics; software used to analyse and determine codon usage; data processing software; downloadable computer software for scientific analysis of genetic sequences |
| Goods and Services | Design and development of software; design of algorithms; analysis, management and review of technical data; genetic engineering services; research relating to genetics; software engineering; design, development and maintenance of software in the fields of recombinant protein production, genetic engineering, immunology, cell engineering, biopharmaceuticals, biotechnology, molecular biology, modulating therapeutics, assay systems and antigens; providing non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; providing non-downloadable software for monitoring patient health; development of machine learning software; software as a service [Saas] featuring software for machine learning; development and testing of computing methods, algorithms and software; design and development of software in the field of culture methods for microbes, bacteria, yeast, fungi and mammalian cells; design, development and maintenance of software in the fields of genomes, genetic mapping, molecular genetics, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assays; contract research services relating to molecular sciences; research services in the field of proteins, antibodies, microorganisms and cells; research and development services; biological, biomedical and pharmacological research, analysis and development services; research and development of biological drug delivery platforms; laboratory services; culturing of cells for scientific or medical research purposes; testing of human tissues and stem cells for scientific or medical research purposes; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; cell programming services; scientific services relating to the isolation and cultivation of human tissues and cells; cell separation services; development of testing methods; diagnostic and testing services; preparation of reports in the field of biotechnology; technical testing, measuring, survey and evaluation services; design and development of scientific cell culture, cell therapy or gene therapy equipment and apparatus; consultancy, information and advisory services relating to all of the aforesaid services |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 7, 2026 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 7, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ingenza Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | Milton Bridge EH26 0GB GB |
| Event Date | Event Description |
| Tuesday, April 7, 2026 | NEW APPLICATION ENTERED |
| Tuesday, April 7, 2026 | APPLICATION FILING RECEIPT MAILED |